Meeting of the Presidential Advisory Council on HIV/AIDS, 11047 [2017-03245]
Download as PDF
Federal Register / Vol. 82, No. 32 / Friday, February 17, 2017 / Notices
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
designated contact person at least
fourteen (14) business days prior to the
meeting. Members of the public will
have an opportunity to provide
comments at the meeting. Public
comments will be limited to three
minutes per speaker. Individuals who
would like to submit written statements
should mail or fax their comments to
the Office of Minority Health at least
seven (7) business days prior to the
meeting. Any members of the public
who wish to have printed material
distributed to ACMH committee
members should submit their materials
to the Designated Federal Officer,
ACMH, Tower Building, 1101 Wootton
Parkway, Suite 600, Rockville,
Maryland 20852, prior to close of
business on Thursday, March 16, 2017.
Dated: February 14, 2017.
Minh Wendt,
Designated Federal Officer, ACMH, Office of
Minority Health, U.S. Department of Health
and Human Services.
[FR Doc. 2017–03247 Filed 2–16–17; 8:45 am]
BILLING CODE 4150–29–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on HIV/AIDS
Department of Health and
Human Services, Office of the Secretary,
Office of the Assistant Secretary for
Health.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services is hereby giving notice that the
Presidential Advisory Council on HIV/
AIDS (PACHA or the Council) will be
holding a meeting to continue
discussions and possibly develop
recommendations regarding People
Living with HIV/AIDS. The meeting will
be open to the public.
DATES: The Council meeting is
scheduled to be held on March 13, 2017,
from 9:00 a.m. to approximately 5:00
p.m. (ET) and March 14, 2017, from 9:00
a.m. to approximately 12:00 p.m. (ET).
The meeting will be open to the public.
ADDRESSES: 330 Independence Avenue
SW., Washington, DC 20201 in the
Snow Room (Conference Room 5051).
FOR FURTHER INFORMATION CONTACT: Ms.
Caroline Talev, Public Health Analyst,
Presidential Advisory Council on HIV/
mstockstill on DSK3G9T082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:38 Feb 16, 2017
Jkt 241001
AIDS, 330 C Street SW., Room L106B,
Washington, DC 20024; (202) 795–7622
or Caroline.Talev@hhs.gov. More
detailed information about PACHA can
be obtained by accessing the Council’s
page on the AIDS.gov Web site at
www.aids.gov/pacha.
SUPPLEMENTARY INFORMATION: PACHA
was established by Executive Order
12963, dated June 14, 1995, as amended
by Executive Order 13009, dated June
14, 1996. In a memorandum, dated July
13, 2010, and under Executive Order
13703, dated July 30, 2015, the
President gave certain authorities to the
PACHA for implementation of the
National HIV/AIDS Strategy for the
United States (Strategy). PACHA is
currently operating under the authority
given in Executive Order 13708, dated
September 30, 2015.
PACHA provides advice, information,
and recommendations to the Secretary
regarding programs, policies, and
research to promote effective treatment,
prevention, and cure of HIV disease and
AIDS, including considering common
co-morbidities of those infected with
HIV as needed, to promote effective HIV
prevention and treatment and quality
services to persons living with HIV
disease and AIDS.
Substantial progress has been made in
addressing the domestic HIV epidemic
since the Strategy was released in July
2010. Under Executive Order 13703, the
National HIV/AIDS Strategy for the
United States: Updated to 2020
(Updated Strategy) was released.
PACHA shall contribute to the federal
effort to improve HIV prevention and
care.
The functions of the Council are
solely advisory in nature.
The Council consists of not more than
25 members. Council members are
selected from prominent community
leaders with particular expertise in, or
knowledge of, matters concerning HIV
and AIDS, public health, global health,
philanthropy, marketing or business, as
well as other national leaders held in
high esteem from other sectors of
society. Council members are appointed
by the Secretary or designee, in
consultation with the White House
Office on National AIDS Policy. The
agenda for the upcoming meeting will
be posted on the AIDS.gov Web site at
www.aids.gov/pacha.
Public attendance at the meeting is
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify Caroline
Talev at Caroline.Talev@hhs.gov. Due to
space constraints, pre-registration for
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
11047
public attendance is advisable and can
be accomplished by contacting Caroline
Talev at Caroline.Talev@hhs.gov by
close of business on Monday, March 6,
2017. Members of the public will have
the opportunity to provide comments
during the meeting. Comments will be
limited to two minutes per speaker. Any
individual who wishes to participate in
the public comment session must
register with Caroline Talev at
Caroline.Talev@hhs.gov by close of
business on Monday, March 6, 2017;
registration for public comment will not
be accepted by telephone. Individuals
are encouraged to provide a written
statement of any public comment(s) for
accurate minute taking purposes. Public
comment will be limited to two minutes
per speaker. Any members of the public
who wish to have printed material
distributed to PACHA members at the
meeting are asked to submit, at a
minimum, 1 copy of the material(s) to
Caroline Talev, no later than close of
business on Monday, March 6, 2017.
Dated: February 9, 2017.
B. Kaye Hayes,
Executive Director, Presidential Advisory
Council on HIV/AIDS.
[FR Doc. 2017–03245 Filed 2–16–17; 8:45 am]
BILLING CODE 4150–43–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel Review of RFA–TR–16–021:
Coordination Center for the CTSA Program
(U24).
Date: March 14, 2017.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\17FEN1.SGM
17FEN1
Agencies
[Federal Register Volume 82, Number 32 (Friday, February 17, 2017)]
[Notices]
[Page 11047]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03245]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Presidential Advisory Council on HIV/AIDS
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of the Assistant Secretary for Health.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S.
Department of Health and Human Services is hereby giving notice that
the Presidential Advisory Council on HIV/AIDS (PACHA or the Council)
will be holding a meeting to continue discussions and possibly develop
recommendations regarding People Living with HIV/AIDS. The meeting will
be open to the public.
DATES: The Council meeting is scheduled to be held on March 13, 2017,
from 9:00 a.m. to approximately 5:00 p.m. (ET) and March 14, 2017, from
9:00 a.m. to approximately 12:00 p.m. (ET). The meeting will be open to
the public.
ADDRESSES: 330 Independence Avenue SW., Washington, DC 20201 in the
Snow Room (Conference Room 5051).
FOR FURTHER INFORMATION CONTACT: Ms. Caroline Talev, Public Health
Analyst, Presidential Advisory Council on HIV/AIDS, 330 C Street SW.,
Room L106B, Washington, DC 20024; (202) 795-7622 or
Caroline.Talev@hhs.gov. More detailed information about PACHA can be
obtained by accessing the Council's page on the AIDS.gov Web site at
www.aids.gov/pacha.
SUPPLEMENTARY INFORMATION: PACHA was established by Executive Order
12963, dated June 14, 1995, as amended by Executive Order 13009, dated
June 14, 1996. In a memorandum, dated July 13, 2010, and under
Executive Order 13703, dated July 30, 2015, the President gave certain
authorities to the PACHA for implementation of the National HIV/AIDS
Strategy for the United States (Strategy). PACHA is currently operating
under the authority given in Executive Order 13708, dated September 30,
2015.
PACHA provides advice, information, and recommendations to the
Secretary regarding programs, policies, and research to promote
effective treatment, prevention, and cure of HIV disease and AIDS,
including considering common co-morbidities of those infected with HIV
as needed, to promote effective HIV prevention and treatment and
quality services to persons living with HIV disease and AIDS.
Substantial progress has been made in addressing the domestic HIV
epidemic since the Strategy was released in July 2010. Under Executive
Order 13703, the National HIV/AIDS Strategy for the United States:
Updated to 2020 (Updated Strategy) was released. PACHA shall contribute
to the federal effort to improve HIV prevention and care.
The functions of the Council are solely advisory in nature.
The Council consists of not more than 25 members. Council members
are selected from prominent community leaders with particular expertise
in, or knowledge of, matters concerning HIV and AIDS, public health,
global health, philanthropy, marketing or business, as well as other
national leaders held in high esteem from other sectors of society.
Council members are appointed by the Secretary or designee, in
consultation with the White House Office on National AIDS Policy. The
agenda for the upcoming meeting will be posted on the AIDS.gov Web site
at www.aids.gov/pacha.
Public attendance at the meeting is limited to space available.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
notify Caroline Talev at Caroline.Talev@hhs.gov. Due to space
constraints, pre-registration for public attendance is advisable and
can be accomplished by contacting Caroline Talev at
Caroline.Talev@hhs.gov by close of business on Monday, March 6, 2017.
Members of the public will have the opportunity to provide comments
during the meeting. Comments will be limited to two minutes per
speaker. Any individual who wishes to participate in the public comment
session must register with Caroline Talev at Caroline.Talev@hhs.gov by
close of business on Monday, March 6, 2017; registration for public
comment will not be accepted by telephone. Individuals are encouraged
to provide a written statement of any public comment(s) for accurate
minute taking purposes. Public comment will be limited to two minutes
per speaker. Any members of the public who wish to have printed
material distributed to PACHA members at the meeting are asked to
submit, at a minimum, 1 copy of the material(s) to Caroline Talev, no
later than close of business on Monday, March 6, 2017.
Dated: February 9, 2017.
B. Kaye Hayes,
Executive Director, Presidential Advisory Council on HIV/AIDS.
[FR Doc. 2017-03245 Filed 2-16-17; 8:45 am]
BILLING CODE 4150-43-P